Innate Pharma (IPH) — Free Cash Flow Generation Index
Innate Pharma (IPH) has a Free Cash Flow Generation Index of 0.91x as of June 2024. Free cash flow of €2.75 Million represents 1% of operating cash flow (€3.04 Million). Read Innate Pharma total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Innate Pharma Free Cash Flow Generation Index (2006–2019)
Historical FCF Generation Index trend for Innate Pharma across 4 annual periods. Explore Innate Pharma (IPH) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Innate Pharma (2006–2019)
Year-by-year Free Cash Flow Generation Index for Innate Pharma. For the full company profile including market capitalisation, see Innate Pharma (IPH) market capitalisation.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2019 | -0.87x | €-30.48 Million | €34.92 Million | €65.40 Million | ▼ -190.5% |
| 2015 | 0.96x | €200.51 Million | €207.91 Million | €7.40 Million | ▼ -1.1% |
| 2011 | 0.98x | €12.66 Million | €12.99 Million | €322.00K | ▲ +189.6% |
| 2006 | -1.09x | €-392.00K | €360.00K | €752.00K | — |